![](/img/cover-not-exists.png)
PO-10 In vivo efficacy of HER1/EGFR tyrosine kinase inhibition in erlotinib resistant PC3 prostate cancer cells is associated to reduced endothelial cell organization and increased inflammatory infiltration
C. Festuccia, G.L. Gravina, P. Muzi, A. Vetuschi, R. Sferra, C. Vicentini, M. BolognaVolume:
120
Year:
2007
Language:
english
DOI:
10.1016/s0049-3848(07)70163-9
File:
PDF, 51 KB
english, 2007